Salivary and serum interleukin-18 in patients with oral lichen planus: A study in an ethnic Chinese population

Inflammation

Volumn 35, Issue 2, 2012, Pages 399-404

  Zhang, Yuanyuan ^a   Liu, Wenzhao ^b   Zhang, Songtao ^c   Dan, Hongxia ^d   Lu, Rui ^d   Wang, Fang ^d   Wang, Jing ^d   Zhou, Min ^d   Zeng, Xin ^d   Lin, Mei ^d   Chen, Qianming ^d   Zhou, Yu ^d  

^a ZHENGZHOU UNIVERSITY   (China)

^b WENZHOU MEDICAL UNIVERSITY   (China)

^c Henan Province Tumor Hospital   (China)

^d SICHUAN UNIVERSITY   (China)

Author keywords

Cytokines; Oral lichen planus; Pathogenesis; Saliva; Serum

Indexed keywords

INTERLEUKIN 18;

ADULT; AGED; ARTICLE; CHINESE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; LICHEN PLANUS; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; SALIVA LEVEL; SCREENING;

ADULT; AGED; ASIAN CONTINENTAL ANCESTRY GROUP; CHINA; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; INTERLEUKIN-18; LICHEN PLANUS, ORAL; MALE; MIDDLE AGED; PROGNOSIS; SALIVA; YOUNG ADULT;

EID: 84863785533     PISSN: 03603997     EISSN: 15732576     Source Type: Journal    
DOI: 10.1007/s10753-011-9327-3     Document Type: Article

References (27)

1. Mollaoglu, N. 2000. Oral lichen planus: A review. The British Journal of Oral & Maxillofacial Surgery 38: 370-377. (Pubitemid 30623946)
2. Eisen, D., M. Carrozzo, J.V. Bagan-Sebastian, et al. 2005. Number V oral lichen planus: Clinical features and management. Oral Diseases 11: 338-349. (Pubitemid 41727231)
3. Thornhill, M.H. 2001. Immune mechanisms in oral lichen planus. Acta Odontologica Scandinavica 59: 174-177. (Pubitemid 33644367)
4. Khan, A., C.S. Farah, and N.W. Savage. 2003. The cytokines in oral lichen planus. Journal of Oral Pathology & Medicine 32: 77-83.
5. Gerdes, N., G.K. Sukhova, P. Libby, et al. 2002. Expression of interleukin (IL)-18 and functional IL-18 receptor on human vascular endothelial cells, smooth muscle cells, and macrophages: Implications for atherogenesis. The Journal of Experimental Medicine 195: 245-257. (Pubitemid 34461268)
6. Dinarello, C.A., and G. Fantuzzi. 2003. Interleukin-18 and host defense against infection. Infectious Diseases 187: 370-384.
7. Alexandrakis, M.G., F.H. Passam, K. Sfiridaki, J. Moschandrea, C. Pappa, D. Liapi, et al. 2004. Interleukin-18 in multiple myeloma patients: Serum levels in relation to response to treatment and survival. Leukemia Research 3: 259-266. (Pubitemid 37550060)
8. Nakamura, H., K. Komastsu, M. Ayaki, et al. 2000. Serum levels of soluble IL-2 receptor, IL-12, IL-18, and IFN-gamma in patients with acute graft-verus-host disease after allogeneic bone marrow transplantation. The Journal of Allergy and Clinical Immunology 106: S45-S50. (Pubitemid 30482834)
9. Liu, W., H. Dan, Z. Wang, et al. 2009. IFN-gamma and IL-4 in saliva of patients with oral lichen planus: A study in an ethnic Chinese population. Inflammation 32: 176-181.
10. Zhang, Y., M. Lin, S. Zhang, et al. 2008. NF-kappaB-dependent cytokines in saliva and serum from patients with oral lichen planus: A study in an ethnic Chinese population. Cytokine 41(2): 144-149.
11. Bai, J., Y. Zhang, M. Lin, et al. 2007. Interleukin-18 gene polymorphisms and haplotypes in patients with oral lichen planus: A study in an ethnic Chinese cohort. Tissue Antigens 70: 390-397. (Pubitemid 47537401)
12. Zhou, G., H. Liu, M. Lin, and G. Tang. 2005. The evaluation criteria for the curative effect of the atrophic and erosive oral lichen plans (on probation). Chinese Journal of Stomatology 40: 92-93.
13. Lozada-Nur, F., and C. Miranda. 1997. Oral lichen planus: Epidemiology, clinical characteristics, and associated diseases. Seminars in Cutaneous Medicine and Surgery 16: 273-277. (Pubitemid 28009575)
14. Pezelj-Ribaric, S., I.B. Prso, M. Abram, I. Glazar, G. Brumini, and M. Simunovic-soskic. 2004. Salivary levels of tumor necrosis factor-alpha in oral lichen planus. Mediators of Inflammation 13 (2): 131-133. (Pubitemid 38698144)
15. Sun, A., J.T. Wang, J.S. Chia, and C.P. Chiang. 2005. Serum interleukin-8 level is a more sensitive marker than serum interleukin-6 level in monitoring the disease activity of oral lichen planus. The British Journal of Dermatology 152: 1187-1192. (Pubitemid 40933416)
16. Gu, G.M., M.D. Martin, R.P. Darveau, E. Truelove, and J. Epstein. 2004. Oral and serum IL-6 levels in oral lichen planus patients. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology and Endodontics 98: 673-678. (Pubitemid 39593611)
17. Rhodus, N.L., B. Cheng, S. Myers, L. Miller, V. Ho, and F. Ondrey. 2005. The feasibility of monitoring NF-kappaB associated cytokines: TNF-alpha, IL-1alpha, IL-6, and IL-8 in whole saliva for the malignant transformation of oral lichen planus. Molecular Carcinogenesis 44: 77-82. (Pubitemid 41397172)
18. Sugerman, P.B., N.W. Savage, L.J. Walsh, Z.Z. Zhao, Z.J. Zhou, A. Khan, et al. 2002. The pathogenesis of oral lichen planus. Critical Reviews in Oral Biology and Medicine 13: 350-355.
19. Simark Mattsson, C., M. Jontell, G. Benrgenholtz, et al. 1998. Distribution of interferon-gamma mRNA-positive cell in oral lichen planus lesions. Journal of Oral Pathology & Medicine 27: 483-488. (Pubitemid 28514885)
20. Simark Mattsson, C., G. Bergenholtz, M. Jontell, et al. 1999. Distribution of interleukin-2-4-10, tumor necrosis factor-alpha and transforming growth factor-beta mRNA in oral lichen planus. Archives of Oral Biology 44: 499-507. (Pubitemid 29264470)
21. Krause, I., G. Valesini, R. Scrivo, and Y. Shoenfeld. 2003. Autoimmune aspects of cytokine and anticytokine therapies. The American Journal of Medicine 115: 390-397. (Pubitemid 37311257)
22. Okamura, H., H. Tsutsi, T. Komatsu, et al. 1995. Cloning of a new cytokine that induces IFN-gamma production by T cells. Nature 378: 88-91.
23. Carrozzo, M., Uboldi de Capei, and E. Dametto. 2004. Tumor necrosis factor-alpha and interferon-gamma polymorphisms contribute to susceptibility to oral lichen planus. Journal of Investigative Dermatology 122: 87-94.
24. Okamoto, I., K. Kohno, T. Tanimoto, K. Iwaki, T. Ishihara, S. Akamatsu, et al. 2000. IL-18 prevents the development of chronic graft-versus-host disease in mice. Journal of Immunology 164: 6067-6074. (Pubitemid 30389857)
25. Fujimori, Y., H. Takatsuka, Y. Takemoto, H. Hara, H. Okamura, K. Nakanaishi, et al. 2000. Elevated interleukin (IL)-18 levels during acute graft-versus-host disease after allogeneic bone marrow transplantation. British Journal Haematology 109: 652-657. (Pubitemid 30415197)
26. Puren, A.J., G. Fantuzzi, Y. Gu, et al. 1998. Interleukin-18 (IFN-gamma-inducing factor) induces IL-8 and IL-1 beta via TNF-alpha production from non-CD14+ human blood mononuclear cells. The Journal of Clinical Investigation 101: 711-721. (Pubitemid 28084257)
27. Choo, R.E., and M.A. Huestis. 2004. Oral fluid as a diagnostic tool. Clinical Chemistry and Laboratory Medicine 42: 1273-1287. (Pubitemid 39600330)